GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization - Sorbonne Université Access content directly
Conference Papers Year : 2022

GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization

PRESENTATION Finale 300822.pdf (2.98 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-04000417 , version 1 (27-02-2023)

Identifiers

  • HAL Id : hal-04000417 , version 1

Cite

France Piétri‐rouxel. GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization. 12th Japanese-French Workshop “New insights in personalized medicine for neuromuscular diseases: From Basic to Applied Myology”, Gisèle Bonne, Sep 2022, Giverny, France. ⟨hal-04000417⟩
8 View
29 Download

Share

Gmail Facebook X LinkedIn More